Prof. Dr. I. Chiricuta Institute of Oncology

Academic/Hospital

Also known as: Prof Dr. I Chiricuta Cluj Napoca Oncology Institute - Breast Cancer Center, Cluj Napoca, Romania | Prof. Dr. I. Chiricuta Institute of Oncology | Prof. Dr. Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Jul 1, 2008

Last known activity

Nov 26, 2018

Timeline

No events for the selected filters.

Drugs by trial phase (11 distinct, 5 trials)

Phase 2 (9 own, 0 via acquisition)

sevoflurane
acetaminophen
lidocaine
bevacizumab
tramadol
capecitabine
atropine
neostigmine
symphoglobulin-d

Phase 1 (2 own, 0 via acquisition)

propofol
fentanyl

Indications

Studied for

Breast Neoplasms
Colorectal Neoplasms
Purpura
Purpura, Thrombocytopenic
Purpura, Thrombocytopenic, Idiopathic

Recent trials (5)

NCT04162535CollaboratorPhase 1Nov 26, 2018
NCT02839668CollaboratorPhase 2Aug 1, 2016
NCT02786329CollaboratorEarly Phase 1Jun 1, 2016
NCT01195298Overall official - principal investigatorPhase 2May 1, 2010
NCT00718692Overall official - principal investigatorPhase 2Jul 1, 2008

Details

Last known activity: Nov 26, 2018